Back to FARALLON CAPITAL MANAGEMENT, L.L.C.

AGIO
Showing 8 of 26 quarters

Position history for FARALLON CAPITAL MANAGEMENT, L.L.C.'s holdings in AGIOS PHARMACEUTICALS INC

FARALLON CAPITAL MANAGEMENT, L.L.C. holds 5.7M shares of AGIO (AGIOS PHARMACEUTICALS INC), worth $192.3M as of 2026-Q1. The position was increased (+10.2% shares). AGIO represents 1.1% of FARALLON CAPITAL MANAGEMENT, L.L.C.'s portfolio.

Current Value

$192.3M

Current Shares

5.7M

Total Value Change

-$51.5M

Total Shares Change

+29,498

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
5.7M
+10.2%
$192.3M1.1%$28.48
53
2025-Q4
Decreased
5.2M
-10.8%
$140.4M0.7%$27.33
0
2025-Q3
Increased
5.8M
+0.2%
$232.1M0.9%$39.27
43
2025-Q2
Increased
5.8M
+1.2%
$191.8M0.8%$33.47
43
2025-Q1
Increased
5.7M
+0.5%
$167M0.9%$30.28
43
2024-Q4
Increased
5.7M
+0.2%
$186.5M0.9%$33.03
43
2024-Q3
Increased
5.7M
+0.1%
$251.5M1.2%$45.61
48
2024-Q2
Increased
5.7M
+1.1%
$243.8M1.2%$43.12
49

Other major holders of AGIO: VANGUARD GROUP INC, Capital International Investors, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used